Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by taylor1988on Aug 05, 2011 1:38pm
376 Views
Post# 18909176

Nibbled some more

Nibbled some morethis morning.

Ultimately you're getting a gold explorer in the Yukon with royalties and cash-rich to prevent dilution as well as de-risking on the way with 3 Resource Estimates planned this year alone.

I think it's the last way to play the Yukon gold rush without paying up too high for those companies that have already surpassed $350 million market caps, let alone $1 billion recently for ATAC.

The Selwyn Basin district drilling is also incredibly intriguing, don't forget why you bought this stock and trade it off for cash in here.

Take a good look at Scottie's posts on the previous pages and super posts and watch the Golden Predator Video.  GPD has staked a massive land package in the Yukon and is doing a great job so far delineating it with 2 new discoveries this year alone.

Bullboard Posts